ReviewFrontiers in cell and developmental biology2021

Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications.

Bo Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.